Egypt: Minapharm Pharmaceuticals mulls $19.48mln capital hike

Reuters Images

Under the board’s recommendation, a total of 60.29mln bonus shares will be distributed, where each shareholder will receive 5.11 bonus shares

Staff Writer, Mubasher

March 15, 2023

PHOTO

Cairo - The board of Minapharm Pharmaceuticals agreed to increase the company’s issued capital by EGP 602.98 million through bonus shares, according to a bourse filing.

Under the board’s recommendation, a total of 60.29 million bonus shares will be distributed, where each shareholder will receive 5.11 bonus shares.

The hike process aims to back the company’s financial position, as the EGP 122.93 million capital does not align with the reserves shown in the income statements.

Last year, the EGX-listed firm inked an exclusive licence agreement with Dubai-based Bioventure and MiGenTra GmbH for the commercialisation of multiple biosimilar candidates developed and manufactured by Alvotech.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.